Octreotide plus total parenteral nutrition in patients with external digestive tract fistulas - An evaluation of our experience

Annals of Gastroenterology

Volumn 18, Issue 4, 2005, Pages 427-433

  Xeropotamos, Nicolaos ^a   Nastos, D ^a   Nousias, V ^a   Katsanos, K H ^a   Christodoulou, D ^a   Tsianos, Epameinondas V ^a   Kappas, A M ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Digestive tract fistulas; Octreotide; Total parenteral nutrition

Indexed keywords

OCTREOTIDE;

ADULT; ARTICLE; CONTROLLED STUDY; DIGESTIVE SYSTEM FISTULA; DISEASE COURSE; EXPERIENCE; FEMALE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; RETROSPECTIVE STUDY; TOTAL PARENTERAL NUTRITION; TREATMENT OUTCOME; UNIVERSITY HOSPITAL;

EID: 34548529543     PISSN: 11087471     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Edmunds H.Jr, Williams GM, Welch CE. External fistulas arising from the gastrointestinal tract. Ann. Surg 1960; 152: 445-470.
2. Halversen RC, Hogle HH, Richards RC. Gastric and small bowel fistulas. Am J Surg 1969; 118: 968-972.
3. Lorenzo GA, Beal JM. Management of external small bowel fistulas. Arch Surg 1969; 99: 394-396.
4. Nassos TP,Braasch JW. External small bowel fistulas: current treatment and results. Surg Clin North Am 1971; 51: 687-692.
5. Nemhauser GM, Brayton D. Enterocutaneous fistulas involving the jejuno-ileum. Am Surg 1967; 33: 16-20.
6. Roback SA, Nicoloff DM. High output enterocutaneous fistulas of the small bowel. Am J Surg 1972; 123: 317-322.
7. West JP, Ring EM, Miller RE. A study of the causes and treatment of external postoperative intestinal fistulas. Surg Obstet Gynecol 1961; 113: 490-496.
8. Chapman R, Foran B, Dunphy JE. Management of intestinal fistulas. Am J Surg 1964;108:157-164.
9. Meguid MM, Campos ACL. Preface: Surgical management of gastrointestinal fistulas. Surg Clin North Am 1996; 76: 11-13.
10. Fischer JE. The pathophysiology of enterocutaneous fistulas. World J Surg 1983; 7: 446-450.
11. McIntyre PB, Ritchie JK, Hawley PR, et al. Management of enterocutaneous fistulas: a review of 132 cases. Br J Surg 1984; 71: 293-296.
12. Rinsema W, Gouma DI, von Meyenfeldt MF, et al. Primary conservative management of external small-bowel fistulas. Acta Chir Scand 1990; 156: 457-462.
13. Schein M, Decker GAG. Postoperative alimentary tract fistulas. Am J Surg 1991; 161: 435-438.
14. Kuvshinoff BW, Brodish RJ, McFadden DW, et al. Serum tranferrin as a prognostic indicator of spontaneous closure and mortality in gastrointestinal cutaneous fistulas. Ann Surg 1993; 217: 615-623.
15. Reber HA, Roberts C, Way L, et al. Management of external gastrointestinal fistulas. Ann Surg 1978; 188: 460-467.
16. Soeters PB, Ebeid AM, Fischer JE. Review of 404 patients with gastrointestinal fistulas: impact of parenteral nutrition Ann Surg 1979; 190: 189-202.
17. Machado MC, Monteiro da Cunha JE, Bacchela T, et al. Surgical treatment of persistent intestinal fistula associated with abdominal evisceration. Int Surg 1988; 73: 133-134.
18. Berry SM, Fischer JE. Enterocutaneous fistulas. Curr Probl Surg 1994; 31: 473-554.
19. Nubiola P, Badia JM, Martinez-Rodenas F, et al. Treatment of 27 postoperative enterocutaneous fistulas with the long half-life somatostatin analogue SMS 201-995. Ann Surg 1989; 210: 56-58.
20. Nubiola-Calogne P, Sancho J, Segura M, et al. Blind evaluation of the effects of OC (SMS 201-995), a somatostatin analogue, on small-bowel fistula output. Lancet 1987; 2: 672-74.
21. Borison DI, Bloom AD, Pritchard TJ. Treatment of enterocutaneous and colocutaneous fistulas with early surgery or somatostatin analog. Dis Colon Rectum 1992; 35: 635-639.
22. Torres AJ, Landa JI, Moreno-Azcoita M, et al. Somatostatin in management of gastrointestinal fistulas: A multicenter trial. Arch Surg 1992; 127: 97-100.
23. Sancho JJ, Di Constanzo J, Nubiola P, et al. Randomized double-blind placebo-controlled trial of early OC in patients with postoperative enterocutaneous fistula. Br J Surg 1995; 82: 638-641.
24. Paran H, Neufeld D, Kaplan O, et al. OC for treatment of postoperative alimentary tract fistulas. World J Surg 1995; 19: 430-434.
25. Martineau P, Shwed JA, Denis R. Is OC a new hope for enterocutaneous and external pancreatic fistulas closure? Am J Surg 1996; 172: 386-390.
26. Alvarez C, McFadden DW, Reber HA. Complicated enterocutaneous fistulas: failure of OC to improve healing. World J Surg 2000; 24: 533-538.
27. Sitges-Serra A, Jaurrieta E, Sitges-Creus A. Management of postoperative enterocutaneous fistulas: The role of parenteral nutrition and surgery. Br J Surg 1982; 69: 147-150.
28. Prickett D, Montgomery R, Cheadle WG. External fistulas arising from the digestive tract. South Med J 1991; 84: 736-739.
29. Rosa D, Yarborough MF, Canizaro PC, et al. One hundred and fourteen fistulas of the gastrointestinal tract treated with total parenteral nutrition. Surg Gynecol Obst 1986; 163: 345-350.
30. Memon AS, Siddiqui FG. Causes and management of postoperative enterocutaneous fistulas. J Coll Physicians Surg Pak 2004; 14: 25-28.
31. Gonzalez-Pinto I, Gonzalez EM. Optimizing the treatment of upper gastrointestinal fistulae. Gut 2001; 49: 22-31.
32. Hesse U, Ysebaert D, De Hemtinne B. Role of somatostatin-14 and its analogues in the management of gastrointestinal fistulae: clinical data. Gut 2001; 49: iv11-iv2l.
33. Hashimoto N, Yasuda C, Ohyanagi H. Pancreatic fistula after pancreatic head resection: incidence, significance and management. Hepatogastroenterology 2003; 20:1658-1660.
34. Alivizatos V, Felekis D, Zorbalas A. Evaluation of the effectiveness of octreotide in the conservative treatment of postoperative enterocutaneous fistulas. Hepatogastroenterology 2002; 49: 1010-2.
35. Barnett SP, Hodul PJ, Creech S, et al. Octreotide does not prevent postoperative pancreatic fistula or mortality following pancreaticoduodenectomy. Am Surg 2004; 70: 222-226.
36. Gouillat C, Gigot JF. Pancreatic surgical complications the case for prophylaxis. Gut 2001; 49: iv32-39.
37. Li-Ling, J, Irving M. Somatostatin and octreotide in the prevention of postoperative pancreatic complications and the treatment of enterocutaneous pancreatic fistulas: a systematic review of randomized controlled trials. Br J Surg 2001; 88: 190-199.
38. Yeo CJ, Cameron JL, Lillemoe KD, et al. Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Results of a prospective randomized placebo-controlled trial. Ann Surg 2000; 232: 419-429.